Sophie Parmentier Batteur

Company: Novartis

Job title: Head of Neurodegeneration

Seminars:

Roundtable Discussion: Reinventing the ALS Target Landscape 2:30 pm

More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas: Looking beyond TDP-43: Are there other RNA binding protein dysfunctions involved in sporadic ALS? Are their specific genetic mutations in ALS that could be addressed with RNA editing technologies? What are the most promising microglia and…Read more

day: Day One PM